Head-to-head · Cost-Efficiency Index
Mochi Health vs Mint Med
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Mochi Health
Shoppers who want obesity-medicine physician access bundled with the prescription, and don't mind two separate line items.
Visit Mochi HealthMint Med
Cost-first shoppers who want the simplicity of one flat price across both semaglutide and tirzepatide, in the 35 states it explicitly serves.
Visit Mint MedThe verdict
Mochi Health takes it, leading the Cost-Efficiency Index 56 to 55. Mochi Health is a San Francisco-based telehealth platform bundling compounded GLP-1 prescriptions with a required $79/mo membership (obesity-medicine physician access, in-app coaching), available in all 50 states. Mint Med still earns a C — Cost-first shoppers who want the simplicity of one flat price across both semaglutide and tirzepatide, in the 35 states it explicitly serves.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Mochi Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Mochi Health | Mint Med |
|---|---|---|
| Cost-Efficiency Index | 56/100 | 55/100 |
| Semaglutide / mo | $178/mo (starting dose, plus a separate fee, compounded) | Not disclosed |
| Tirzepatide / mo | $278/mo (starting dose, plus a separate fee, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $2,136 | — |
| Tirzepatide / yr (modeled) | $3,336 | — |
| Coverage | 15 states | 36 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #330 | #334 |
Mochi Health
56/100Where the value is
- Names five board-certified obesity-medicine physicians on its About page (Valledor, Jones, Barrick, A. Patel, Am. Patel MDs/DOs), unusual specificity for this tier of provider
- Available in all 50 states per the About page, a real expansion from the network dataset's outdated '15 states'
- Membership includes ongoing care-team messaging and coaching, not just a one-time prescription
The tradeoffs
- The advertised '$99' and '$199' medication prices are NOT the monthly cost — a separate $79/mo membership is mandatory and stacks on top, so the real floor is $178/mo (semaglutide) and $278/mo (tirzepatide)
- No compounding pharmacy is named anywhere on the site, including a dedicated /pharmacy page that markets the partnership program without ever identifying a partner
Mint Med
55/100Where the value is
- Single, simple flat price ($159/mo) applies to any dose of either drug — no dose-escalation surcharge structure to parse
- No membership fee ('NO memberships!') and cancellation requires only 48 business hours notice
- Explicit immediate-refund commitment if a clinical reviewer finds the applicant ineligible
The tradeoffs
- Payment is collected upfront, before a clinician has reviewed and approved the prescription — patients front the money before knowing they'll be approved
- Only 35 states are served by name — notably absent are several populous states not on the published list, so most shoppers should check it before assuming eligibility
Regulatory note: the FDA issued a warning letter to Glow Medispa, LLC dba Mint Med in June 2026. We still list and link to Mint Med; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.